BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4211468)

  • 21. Evidence for the possible immunogenicity of delta 9-tetrahydrocannabinol (THC) in rodents.
    Nahas GG; Zagury D; Schwartz IW; Nagel MD
    Nature; 1973 Jun; 243(5407):407-8. PubMed ID: 4743633
    [No Abstract]   [Full Text] [Related]  

  • 22. Interferon-
    Henriquez JE; Rizzo MD; Crawford RB; Gulick P; Kaminski NE
    J Pharmacol Exp Ther; 2018 Oct; 367(1):49-58. PubMed ID: 30026298
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of delta-9-tetrahydrocannabinol on social behaviour in the laboratory mouse and rat.
    Cutler MG; Mackintosh JH
    Psychopharmacologia; 1975 Nov; 44(3):287-9. PubMed ID: 1239783
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of delta-9-tetrahydrocannabinol on mitogenic and antigenic stimulation of lymphoid cells from inbred hamsters infected with Treponema pallidum subsp. pallidum.
    Paradise LJ; Pruitt A; Burgess AW
    Adv Exp Med Biol; 1991; 288():127-33. PubMed ID: 1659128
    [No Abstract]   [Full Text] [Related]  

  • 25. Studies on the effects of 1 -tetrahydrocannabinol ( 1 -THC) and DDT on the hepatic microsomal metabolism of 1 -THC and other compounds in the rat.
    Kupfer D; Levin E; Burstein SH
    Chem Biol Interact; 1973 Jan; 6(1):59-66. PubMed ID: 4689910
    [No Abstract]   [Full Text] [Related]  

  • 26. In vivo and in vitro effects of delta9-tetrahydrocannabinol on rats liver microsomal drug-metabolizing enzymes.
    Mitra G; Poddar MK; Ghosh JJ
    Toxicol Appl Pharmacol; 1976 Mar; 35(3):523-30. PubMed ID: 1265765
    [No Abstract]   [Full Text] [Related]  

  • 27. Relative pharmacological potency in mice of optical isomers of delta 1-tetrahydrocannabinol.
    Jones G; Pertwee RG; Gill EW; Paton WD; Nilsson IM; Widman M; Agurell S
    Biochem Pharmacol; 1974 Jan; 23(2):439-46. PubMed ID: 4813356
    [No Abstract]   [Full Text] [Related]  

  • 28. The inhibition of lymphocyte blastogenesis by asparaginase: critical role of glutamine in both T and B lymphocyte transformation.
    Kitoh T; Asai S; Akiyama Y; Kubota M; Mikawa H
    Acta Paediatr Jpn; 1992 Dec; 34(6):579-83. PubMed ID: 1285501
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suppression of lymphocyte transformation after aspirin ingestion.
    Crout JE; Hepburn B; Ritts RE
    N Engl J Med; 1975 Jan; 292(5):221-3. PubMed ID: 1078593
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of delta9-tetrahydrocannabinol on rat liver microsomal lipid peroxidation.
    Mitra G; Poddar MK; Ghosh JJ
    Toxicol Appl Pharmacol; 1975 Dec; 34(3):525-8. PubMed ID: 1872
    [No Abstract]   [Full Text] [Related]  

  • 31. The effects of delta 1-tetrahydrocannabinol on cyclic AMP levels in WI-38 fibroblasts.
    Kelly LA; Butcher RW
    Biochim Biophys Acta; 1973 Sep; 320(2):540-4. PubMed ID: 4356301
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of inhibitors of eicosanoid synthesis upon lymphocyte proliferation.
    Calder PC; Bond JA; Newsholme EA
    Biochem Soc Trans; 1991 Apr; 19(2):88S. PubMed ID: 1889681
    [No Abstract]   [Full Text] [Related]  

  • 33. Actions of delta9-tetrahydrocannabinol on neuromuscular transmission in the rat diaphragm.
    Hoekman TB; Dettbarn WD; Klausner HA
    Neuropharmacology; 1976 May; 15(5):315-9. PubMed ID: 180449
    [No Abstract]   [Full Text] [Related]  

  • 34. The effects of chronic treatment with delta 9-tetrahydrocannabinol on catecholamine synthesis in the rat.
    Mazurkiewicz-Kwilecki IM; Filczewski M
    Psychopharmacologia; 1973 Oct; 33(1):71-9. PubMed ID: 4797647
    [No Abstract]   [Full Text] [Related]  

  • 35. Inhibition of human T-lymphocyte activation by macrolide antibiotic, roxithromycin.
    Konno S; Adachi M; Asano K; Okamoto K; Takahashi T
    Life Sci; 1992; 51(24):PL231-6. PubMed ID: 1447946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Uterotrophic effect of delta-9-tetrahydrocannabinol in ovariectomized rats.
    Solomon J; Cocchia MA; Gray R; Shattuck D; Vossmer A
    Science; 1976 May; 192(4239):559-61. PubMed ID: 1257790
    [No Abstract]   [Full Text] [Related]  

  • 37. Hypothermic action of delta 9-tetrahydrocannabinol, 11-hydroxy-delta 9-tetrahydrocannabinol and 11-hydroxy-delta 8-tetrahydrocannabinol in mice.
    Haavik CO; Hardman HF
    Life Sci; 1973 Dec; 13(12):1771-8. PubMed ID: 4777336
    [No Abstract]   [Full Text] [Related]  

  • 38. The effect of delta1-tetrahydrocannabinol on the release of (3H-(-)-noradrenaline from the isolated vas deferens of the rat.
    Graham JD; Lewis MJ; Li DM
    Br J Pharmacol; 1974 Oct; 52(2):233-6. PubMed ID: 4451818
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differing effects of delta-9-tetrahydrocannabinol (THC) on murine spleen cell populations dependent upon stimulators.
    Pross SH; Nakano Y; Widen R; McHugh S; Newton CA; Klein TW; Friedman H
    Int J Immunopharmacol; 1992 Aug; 14(6):1019-27. PubMed ID: 1330945
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lack of tolerance to the bradycardic effect of delta 9-trans-tetrahydrocannabinol in rats.
    Kaymakçalan S; Sivil S
    Pharmacology; 1974; 12(4-5):290-5. PubMed ID: 4449891
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.